Vitamin Health, Inc. v. Hartford Casualty Insurance Company
Filing
60
OPINION AND ORDER Granting 15 Motion for Summary Judgment; Denying 17 Motion for Summary Judgment. Signed by District Judge Sean F. Cox. (JMcC)
UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF MICHIGAN
SOUTHERN DIVISION
Vitamin Health, Inc.,
Plaintiff,
v.
Case No. 15-10071
Hartford Casualty Insurance Co.,
Honorable Sean F. Cox
Defendant.
_________________________________/
OPINION AND ORDER
GRANTING HARTFORD’S SUMMARY JUDGMENT MOTION & DENYING
VITAMIN HEALTH’S PARTIAL SUMMARY JUDGMENT MOTION
This is an insurance coverage case. On January 1, 2015, Plaintiff/Counter-Defendant
Vitamin Health, Inc. (“Vitamin Health”) filed a Complaint for declaratory relief and breach of
contract against Defendant/Counter-Plaintiff Hartford Casualty Insurance Co. (“Hartford”).
(D.E. No. 1). In it, Vitamin Health seeks an order from this Court declaring that: Hartford is
required to defend Vitamin Health in an action currently pending against Vitamin Health in U.S.
District Court of the Western District of New York (“Underlying Action”); and that Hartford is
required to indemnify Vitamin Health for any judgment it may face as a result of the Underlying
Action’s false advertisement claim against it. On February 25, 2015, Hartford filed a CounterClaim for declaratory relief, seeking an order from this Court declaring that Hartford does not
owe Vitamin Health any defense or indemnity obligations for the Underlying Action. (D.E. No.
4).
This matter is before the Court on Hartford’s Motion for Summary Judgment (D.E. No.
1
15) and Vitamin Health’s Cross-Motion for Partial Summary Judgment (D.E. No. 17). For the
reasons set forth below, the Court shall GRANT Hartford’s Motion and DENY Vitamin
Health’s Motion.
BACKGROUND
A.
Factual Background
In order to provide context, the Court shall first briefly discuss the Underlying Action,
which Vitamin Health alleges Hartford is obligated to defend and indemnify.
1.
The Underlying Action
Vitamin Health is in the business of manufacturing supplements for eye health. (Pl.’s
Stmt. ¶ 6). Vitamin Health’s products are intended to reduce the risk of developing age-related
macular generation. (Def.’s Stmt. ¶ 1). Vitamin Health advertises its products as AREDS 2compliant, indicating to consumers that the products contain the combination of vitamins
recommended by the second Age-Related Eye Disease Study (AREDS) conducted by the
National Eye Institute of the National Institutes of Health. (Def.’s Stmt. ¶ 1).
On September 16, 2013, Bausch & Lomb (“Bausch”) filed a complaint against Vitamin
Health in the United States District Court for the Western District of New York, alleging patent
infringement. (Compl. Ex. A). Like Vitamin Health, Bausch also manufactures supplements for
eye health. (Pl.’s Stmt. ¶ 6). In an amended complaint filed on April 21, 2014, Bausch alleged
two counts of patent infringement and a third count of false advertising. (Def.’s Stmt. ¶ 3).
Bausch’s false advertising claim was based on conduct allegedly undertaken by Vitamin Health
after the filing of Bausch’s initial complaint. Specifically, Bausch alleged that Vitamin Health
“purported to change the formulation” of its product to contain a vitamin combination that
2
allegedly does not comport with the AREDS 2 formula. (Def.’s Stmt. ¶ 3). Vitamin Health
allegedly continues to falsely advertise its products as AREDS 2 compliant, despite the fact that
they are not.
The following factual allegations are relevant to the false advertising claim:
37.
After Bausch & Lomb filed its original Complaint, Vitamin Health purported to
change the formulation of its AREDS 2 products to contain 25 mg of zinc, rather
than the AREDS 2 recommended formula containing 80 mg of zinc...
38.
On information and belief, despite no longer containing the AREDS 2
recommended 80 mg of zinc, Vitamin Health markets Vitamin Health’s Viteyes®
AREDS 2 25 mg zinc products with the term “AREDS 2" prominently displayed
on their labels
39.
On information and belief, Vitamin Health markets and promotes the Viteyes®
AREDS 2 25 mg zinc products as based on the results of the AREDS 2 study
carried out by the National Institutes of Health. The 2013 JAMA journal article
by Dr. Chew et al., discussed above in Paragraph 35, is cited on the Viteyes®
website as source material for its claims.
40.
Vitamin Health’s labeling, promotion and marketing of its Viteyes® AREDS 2 25
mg zinc products as the AREDS 2-recommended formulations are false and/or
likely to mislead or confuse consumers
41.
Vitamin Health’s Viteyes® AREDS 2 25 mg zinc products are marketed as
competing products to Bausch & Lomb’s PreserVision® products. The
distribution and sale of the Viteyes® AREDS 2 25 mg zinc products has caused
and will continue to cause Bausch & Lomb to lose sales of its PreserVision®
AREDS 2 products, to both existing and future Bausch & Lomb customers
42.
Vitamin Health’s marketing and promotional statements for its Viteyes® AREDS
2 25 mg zinc products, stating that these products are based on the
recommendations made by NEI researchers following the results of the AREDS 2
study, are materially false statements that are likely to cause consumer confusion,
mistake, or deception as to the quality and content of the Viteyes® AREDS 2 25
mg products. These are material misrepresentations upon which customers or
potential customers have relied, and will rely. Vitamin Health’s actions therefore
mislead and harm customers and consumers in violation of Section 43(a) of the
Lanham Act, 15 U.S.C. § 1125(a).
3
(D.E. No. 1, Compl. Ex. B ¶¶ 37-42).
Vitamin Health tendered defense of the Underlying Action’s amended complaint to
Hartford. (Def.’s Stmt. ¶ 6). Vitamin Health sought coverage from Hartford under annual
insurance policies issued to Vitamin Health over the course of nine years. (Def.’s Stmt. ¶ 7).
Vitamin Health specifically asserted that the false advertising claim fell within the policies’
definition of “personal and advertising injury.” (Def.’s Stmt. ¶ 8). Hartford disagreed and
denied defense.
2.
Applicable Insurance Provisions
It is undisputed that the only policies at issue here are the policies in effect beginning on
December 27, 2012 through December 27, 2013 and December 27, 2013 through December 27,
2014. (“Hartford Policies” or “Policies”). Subject to their stated conditions and exclusions, the
Hartford Policies provided both business liability and umbrella liability insurance coverage to
Vitamin Health. (Pl.’s Stmt. ¶ 2).
Business liability coverage (defense and indemnity) extends to: (1) bodily injury; (2)
property damage; and (3) personal and advertising injury. At the center of the parties’ dispute is
the “personal and advertising injury” provision, which reads, in pertinent part, that insurance
coverage applies to “‘personal and advertising injury’ caused by an offense arising out of your
business, but only if the offense was committed in the ‘coverage territory’ during the policy
period.” Personal and advertising injury is defined, inter alia, as:
Oral, written or electronic publication of material that slanders or libels a person
or organization or disparages a person’s or organization’s goods, products or
services
....
Copying, in your “advertisement”, a person’s or organization’s “advertising idea”
or style of “advertisement”
4
(Def.’s Ex. 12 at HC000111).
Coverage Exclusions
Vitamin Health’s coverage under the Policies is subject to several relevant policy
exclusions. First, the policies at issue contain an endorsement, which provides that coverage
does not extend to “personal and advertising injury” claims:
(7) (a) Arising out of any violation of any intellectual property right such
as copyright, patent, trademark, trade name, trade secret, service mark or
other designation of origin or authenticity; or
(b) Any injury or damage alleged in any claim or “suit” that also alleges
an infringement or violation fo any intellectual property right, whether
such allegation of infringement or violation is made by you or by any
other party involved in the claim or “suit, regardless of whether this
insurance would otherwise apply
However, this exclusion does not apply if the only allegation in the claim or
“suit” involving any intellectual property right is limited to:
(1) Infringement in your “advertisement”, of:
(a) Copyright;
(b) Slogan; or
(c) Title of any literary or artistic work; or
(2) copying, in your “advertisement”, a person’s or organization’s
“advertising idea” or style of “advertisement”.
(Def.’s Ex. 11 at HC001080).
The Policies also exclude personal and advertising injury “[a]rising out of the failure of
goods, products or services to conform with any statement of quality or performance made in
your ‘advertisement.’” (Def’s Ex. 4 at HC000248).
B.
Procedural Background
On January 9, 2015, after Hartford denied defense of the Underlying Action’s amended
5
complaint, Vitamin Health filed this action. (Compl.). Vitamin Health alleges the following:
Count I – Declaratory Judgment; and Count II – Breach of Contract. As to Count I, Vitamin
Health seeks a determination of the rights and duties of the parties and a declaration that the false
advertising claims asserted in the Underlying Action’s amended complaint constitute covered
claims and “personal and advertising injury” within coverage of the Hartford Policies, and not
subject to any exclusions. (Compl. ¶ 26). As to Count II, Vitamin Health alleges that Hartford
has breached the terms of their contract by failing to pay the defense costs, charges and expenses
incurred by Vitamin Health in the Underlying Action and by failing to indemnify Vitamin Health
for any judgment that may result from the “personal and advertising injury” claims alleged in the
Underlying Action’s false advertising count. (Compl. ¶ 33). Hartford filed a counter-claim on
February 25, 2015, seeking declaratory relief. (D.E. No. 4). Hartford specifically requests an
order from the Court stating that it has no defense or indemnity obligations owing to Vitamin
Health for the Underlying Action. Id.
On October 30, 2015, Hartford filed a Motion for Summary Judgment. On that same
day, Vitamin Health filed a Cross-Motion for Partial Summary Judgment. The motions have
been fully briefed by the parties.
In its motion, Hartford advances arguments to support the position that its duty to defend
and indemnify Vitamin Health has not been triggered. (D.E. No. 15, Def.’s Br.). Hartford
specifically asserts that: (1) the Underlying Action’s false advertising claim is not a covered
“personal and advertising injury” offense because it does not arguably state a claim for product
disparagement; and (2) that even if the Underlying Action’s false advertising claim constituted
product disparagement, it is nevertheless barred by the following two exclusions: the intellectual
6
property exclusion, and the failure to conform exclusion. Vitamin Health’s arguments in
response to Hartford’s motion largely mirror the arguments advanced in its cross motion for
partial summary judgment, which the Court briefly summarizes below. (D.E. No. 36, Pl.’s
Resp.).
In Vitamin Health’s cross motion for partial summary judgment, Vitamin Health asserts
that the Underlying Action’s false advertising claim triggers Hartford’s duty to defendant
because it is arguably a claim for implicit product disparagement. (D.E. No. 17, Pl.’s Br.).
Vitamin Health also argues that none of the exclusions under the Policies bar coverage.
Hartford’s response largely mirrors the arguments advanced in its motion. (D.E. No. 32, Def.’s
Resp.).
STANDARD
Under Fed. R. Civ. P. 56(c), summary judgment is proper “if the pleadings, depositions,
answers to interrogatories, and admissions on file, together with the affidavits, if any, show that
there is no genuine issue as to any material fact and that the moving party is entitled to a
judgment as a matter of law.” Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1984), quoting FED.
R. CIV. P. 56(c).
“The party that moves for summary judgment has the burden of showing that there are no
genuine issues of material fact in the case.” LaPointe v. United Autoworkers Local 600, 8 F.3d
376, 378 (6th Cir. 1993). “The moving party may meet its burden by showing that the
nonmoving party lacks evidence to support an essential element of its case.” Barnhart v.
Pickrel, Schaeffer & Ebeling Co., 12 F.3d 1382, 1389 (6th Cir. 1993). The plaintiff must come
forth with more than a “mere scintilla of evidence” in support of his or her position in order to
7
survive summary judgment. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 251 (1986). “The
court must view the evidence, all facts, and any inferences that may permissibly be drawn from
the facts in the light most favorable to the nonmoving party.” Matsushita Elec. Indus. Co. v.
Zenith Radio Corp., 475 U.S. 574, 587 (1986).
ANALYSIS
As threshold matter, Michigan law shall govern the underlying dispute because the
Court’s jurisdiction is premised upon diversity of citizenship. Michigan First Credit Union v.
CUMIS Ins. Soc’y, Inc., 641 F.3d 240, 251-52 (6th Cir. 2011) (internal citations omitted).
Under Michigan law, an insurance policy is considered to be a contract—an agreement
between two parties. McGuirk Sand & Gravel, Inc. v. Meridian Mut. Ins. Co., 220 Mich. App.
347, 353 (Mich. App. 1996) (quoting Auto-Owners Ins. Co. v. Churchman, 440 Mich. 560, 56667 (1992)). Thus, in resolving coverage disputes, “[t]he court must look at the contract as a
whole and give meaning to all of its terms.” Id. A clause in an insurance contract is valid if it is
clear, unambiguous, and not against public policy. Id.
“Interpretation of an insurance policy ultimately requires a two-step inquiry: first, a
determination of coverage according to the general insurance agreement, and second, a decision
regarding whether an exclusion applies to negate coverage.” Travelers Prop. Cas. Co. of Am. v.
Peaker Servs., Inc., 306 Mich. App. 178, 184-85 (2014) (internal quotations omitted). The
insured bears the burden of establishing coverage under the terms of the policy, while the insurer
bears the burden of establishing an absence of coverage. Scott v. State Farm Fire & Cas. Co., 86
F. Supp. 3d 727, 734 (E.D. Mich. 2015) (internal citation omitted).
8
A.
Hartford Does Not Have A Duty To Defend The Underlying Action
Pursuant to Michigan law, “[t]he duty of the insurer to defend the insured depends upon
the allegations in the complaint of the third party in his or her action against the insured.”
Citizens Ins. Co. v. Secura Ins., 279 Mich. App. 69, 74 (2008) (internal citations and quotations
omitted). Accordingly, “an insurance company has a duty to defend its insured if the allegations
of the underlying suit arguably fall within the coverage of the policy.” Salvati Ins. Grp., Inc. v.
Utica Mut. Ins. Co., 45 F. Supp. 3d 637, 642 (E.D. Mich. 2014). “The duty to defend cannot be
limited by the precise language of the pleadings.” Citizens Ins. Co., 279 Mich. App. at 75
(internal citations and quotations omitted). “The insurer has the duty to look behind the third
party’s allegations to analyze whether coverage is possible.” Id.
1.
The Underlying Action’s False Advertising Claim Does Not Constitute
“Personal and Advertising Injury” Under The Policies
At the crux of the parties’ dispute is whether the false advertising allegations in the
Underlying Action could potentially fall within the policy’s coverage of “personal and
advertising injury.” Under the Policies, coverage extends to “personal and advertising injury”
offenses resulting from “[o]ral, written or electronic publication of material that ... disparages a
person’s or organization’s goods, products, or services.” (Def.’s Ex. 11 at HC001007-1008)
(emphasis added). Thus, the question turns on whether the Underlying Action can arguably be
read to allege that Vitamin Health disparaged Bausch & Lomb’s products in its written
publication. Disparagement is ordinarily defined as “to discredit or bring reproach upon by
comparing with something inferior.” Acme United Corp. v. St. Paul Fire & Marine Ins. Co.,
214 F. App’x 596, 599 (7th Cir. 2007) (quoting Webster’s Third New International Dictionary
(unabridged) 653 (1981)).
9
The Court finds that there can be no disparagement, where, as here, a policy holder is
alleged to have misrepresented the content of its own product, and not its competitor’s. Here, the
false advertising claim in the Underlying Action arose out of Vitamin Health’s alleged “knowing
and willful false and misleading labeling of its products.” (Compl. Ex. B ¶ 33) (emphasis
added). The underlying complaint focuses on Vitamin Health’s alleged misrepresentation that
its Viteyes® products are AREDS 2-compliant. Because Viteyes® products are marketed as
competing products to Bausch & Lomb’s products, their distribution and sale is alleged to have
caused Bausch and Lomb to lose sales. The underlying complaint further states that Vitamin
Health’s AREDS 2 misrepresentations “are likely to cause consumer confusion, mistake, or
deception as to the quality and content of the Viteyes® AREDS 2" products. Id. ¶ 42 (emphasis
added).
Vitamin Health admits that the Underlying Action does not allege “that Vitamin Health
made statements that directly referred to Bausch & Lomb’s” products. (Pl.’s Resp. at 5).
Instead, Vitamin health argues that the false advertising claim alleges that its advertisements
implicitly disparaged Bausch & Lomb’s products. To support this contention, Vitamin Health
points to Bausch & Lomb’s website advertisements, which allegedly represent that Bausch &
Lomb products are the “first and only” AREDS 2 compliant products on the market. Vitamin
Health appears to be arguing that Bausch & Lomb’s website ads, coupled with the false
advertising allegations in its amended complaint, constitute disparagement by implication.
According to Vitamin Health, this type of false comparison disparages Bausch & Lomb’s
products. Vitamin Health’s reasoning as to this point is flawed for a number of reasons.
10
First, in making the above argument, Vitamin Health mistakenly relies on E.piphany, Inc.
v. St. Paul Fire & Marine Ins. Co., 590 F. Supp. 2d 1244 (N.D. Cal. 2008). There, the court
determined that the allegations in the underlying complaint established disparagement by “clear
implication.” Id. at 1253. The court reasoned that the policy holder’s “statement that it was ...
‘the only component-based, fully-J2EE complete CRM suite available’ necessarily suggest[ed]
that competitor products did not have such capabilities.” Id. The court concluded that the
“gravamen of the Underlying Complaint ... [was] that [the policy holder] made false claims
about the superiority of its own products, which clearly and necessarily implied the inferiority of
Sigma’s competing products, resulting in damages to Sigma.” Id. Unlike the underlying
complaint in E.piphany, the underlying complaint at issue here does not allege that Vitamin
Health made any false claims of superiority. In fact, the reverse is true: Vitamin Health has
argued that it is Bausch and Lomb that allegedly advertises its products as superior to its
competitors.
Second, Vitamin Health has not persuasively distinguished the cases relied upon by
Hartford.1 In Welch Foods, Inc. v. Nat’l Union Fire Ins. Co., 2010 WL 3928704 (D. Mass. Oct.
1 2010), the court denied a claim for coverage under facts analogous to facts presented here.
Like Vitamin Health, the policy holder in Welch Foods was covered for “‘personal and
advertising injury,” which was defined in part as arising out of “[o]ral or written publication, in
any manner, of material that ... disparages a person’s or organization’s goods, products or
services ...’” Id. at *3 (internal citations omitted) (emphasis in original). The underlying
1
The Court shall only discuss Hartford’s reliance on Welch Foods since it is most
analogous to the facts presently before the Court.
11
complaint in Welch Foods alleged that Welch Foods Inc. (policy holder) engaged in false and
misleading advertising. Specifically, the underlying plaintiff alleged that the policy holder’s use
of pomegranates on its label misleads consumers into believing that its white grape pomegranate
juice contains actual pomegranate juice. Id. at *1. The court reasoned that the policy holder’s
advertisements “did not disparage POM or its products by making false claims about them;
rather [the policy holder was] alleged to have misrepresented the content of its own product. Id.
(emphasis in original). The court further distinguished the case before it from cases “in which
one competitor is suing another for false claims about the superiority of its own products. Id.
(contrasting E.piphany, 590 F. Supp. 2d at 1253-54). Vitamin Health attempts to distinguish
Welch Foods by arguing that the facts present in E.piphany are “precisely what has occurred”
here. However, for reasons already stated, Vitamin Health is mistaken as to this point.
Accordingly, Welch Foods appears to be strikingly on point, and Vitamin Health has not
persuaded the Court otherwise.
Vitamin Health also mistakenly relies on Jar Laboratories, LLC v. Great American E&S
Ins. Co., 945 F. Supp. 2d 937 (N.D. Ill 2013), for the proposition that misleading comparisons
between a policy holder’s products and its competitor’s products could trigger an insurer’s duty
to defend against claims for advertising injury based on disparagement. (Pl.’s Br. at 14-15, 1718). Jar Laboratories is factually distinct from the present case. There, the underlying
complaint alleged that the policy holder’s “statements communicated ‘false/misleading
messages’ about [the underlying plaintiff’s product].” Jar Laboratories, 945 F. Supp. 2d at 943
(emphasis added). Here, no such allegations exist.
In all, Vitamin Health has not established that the Underlying Action’s false advertising
12
claim triggers Hartford’s duty to defend.2 It simply cannot be shown, or inferred, that the false
advertising claim is arguably a claim for product disparagement. This is especially true in
circumstances where, as here, a policy holder is not alleged to have made or implied false claims
about its competitor’s products or the superiority of its own products. Just as in Welch Foods,
[t]he gravamen of the underlying claim here is false advertising, not product disparagement.”
Welch Foods, Inc., 2010 WL 3928704 at *3. Accordingly, the Court finds that the claims in the
Underlying Action are not covered by the Policies.
2.
The Underlying Action’s False Advertising Claim Is Also Subject To
Exclusions Under The Hartford Policies
Even if the Court were to determine that the Underlying Action’s false advertising claim
fell within the insuring agreement, which it does not, it is nevertheless excluded under the
following two policy exclusions: (1) the intellectual property exclusion; and/or (2) the failure to
conform exclusion.
Typically, exclusions in an insurance policy should be construed strictly in favor of the
insured. McGuirk Sand v. Meridian Mut. Ins. Co., 220 Mich. App. 347, 353 (1996). However,
“[c]lear and specific exclusions” must be given effect so as to avoid holding an insurance
company liable for a risk it did not assume. Id.
2
Vitamin Health also summarily asserts that the false advertising claim constitutes
disparagement because it alleges “that Vitamin Health has ‘mislead and harm[ed] consumers and
customers in violation of Section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a).’” (Pl.’s Br. at
19). Rather than provide any meaningful analysis, Vitamin Health merely recites Section 43(a)
and states that the “allegations fall squarely within the definition of ‘personal and advertising
injury’ in the Hartford Policies.” Id. This argument is without merit. While a Lanham Act
claim that alleges misrepresentations regarding another’s goods or products may implicate
disparagement, the same cannot be said about a Lanham Act claim that alleges
misrepresentations about one’s own goods or products.
13
a.
Intellectual Property Exclusion
The policy in effect at the time of the Underlying Action’s amended complaint includes
an endorsement, which modified the personal and advertising injury exclusion in the following
way:
p. Personal and Advertising Injury:
(7) (a) Arising out of any actual or alleged infringement or violation of
any intellectual property right, such as... patent; or
(b) Any injury or damage alleged in any claim or “suit” that also
alleges an infringement or violation of any intellectual property right,
whether such allegation of infringement or violation is made by you or by
any other party involved in the claim or “suit”, regardless of whether this
insurance would otherwise apply.
(Def.’s Ex. 11, at HC001080) (emphasis added).
The Court finds that subsection (7)(b) of the above exclusion clearly and unambiguously
bars coverage in situations where, as here, a claim of false advertising is alleged in the same
complaint alleging patent infringement. Notably, Vitamin Health does not dispute that the
Underlying Action’s false advertising claim is alleged in a suit that also alleges patent
infringement claims. Instead, Vitamin Health’s argument largely pertains to subsection (7)(a) of
the above exclusion. Vitamin Health cites various cases with similar “arising out of” language
and states that such language cannot be read to exclude allegations of false advertising and
disparagement. The problem with Vitamin Health’s argument is that it wholly disregards
subsection (7)(b).
Moreover, Vitamin Health does not acknowledge, or attempt to distinguish, the numerous
cases cited by Hartford where courts have interpreted subsection (7)(b)’s same language in a
manner consistent with Hartford’s position. (Def.’s Br. at 17) (citing cases in which courts have
14
found no duty to defend where an intellectual property exclusion excluded coverage for
advertising injury claims alleged in a suit that also alleged intellectual property claims).
Vitamin Health concludes by making the following cursory assertion:
Moreover, if Hartford wished to use this exclusion in the manner it suggests, it
should have stated that “any personal or advertising injury or damage alleged in
any claim or ‘suit’ that also alleges an infringement or violation of any
intellectual property right, whether such allegation of infringement or violation is
made by you or by any other party involved in the claim or ‘suit’, regardless of
whether this insurance would otherwise apply.” Hartford cannot use the general
undefined term of ‘injury’ to supersede the defined phrase and separate coverage
grant for “personal and advertising injury.”
(Pl.’s Resp. at 16).
This is the only argument advanced by Vitamin Health that is arguably aimed at
subsection (7)(b). Vitamin Health’s position here is flawed for a number of reasons. As an
initial matter, Vitamin Health does not support this argument with any analysis or relevant law.
Further, Vitamin Health’s argument takes the word “injury” out of context. When interpreting
an insurance policy, courts must look at the contract as a whole, giving meaning to all of its
terms. Auto-Owners, 440 Mich. 560 at 566-67. The applicable exclusion here appears in an
endorsement titled, “Amendment of Exclusions and Definition - Personal and Advertising
Injury.” (Def.’s Ex. 11, at HC001080). The endorsement states that it modifies the “Personal
and Advertising Injury” exclusion in the business liability coverage form. Directly preceding
subsections p(7)(a) and (b) is section p. Section p is titled personal and advertising injury.
Taken in context, subsection (7)(b)’s reference to “any injury or damage” clearly includes
“personal and advertising injury.” And finally, in making this argument, Vitamin Health
disregards the way this exclusion has been interpreted by other courts.
b.
Failure to Conform Exclusion
15
The Hartford Policies also clearly and unambiguously bar coverage for “personal and
advertising injury” arising out the failure of goods, products, or services to conform with any
statement of quality or performance made in one’s ‘advertisement. (Def.’s Ex. 11, at
HC000993).
Here, the false advertising claim alleges that Vitamin Health falsely represents its
products as AREDS 2 compliant. This representation is a statement of quality as to Vitamin
Health’s own products. Accordingly, the false advertising claim arises out of Vitamin Health’s
failure to conform with the representation that its products are AREDS 2 compliant. This
squarely falls within the policy’s failure to conform exclusion.
B.
Hartford Does Not Have A Duty to Indemnify Vitamin Health
An insurer's duty to defend is broader than the duty to indemnify under Michigan law;
therefore, if no duty to defend arises pursuant to the policy's terms, the more limited duty of
indemnification cannot be imposed by that policy. Scott, 86 F. Supp. 3d at 733.
Here, Vitamin Health has not established Hartford’s duty to defend. Accordingly, there
is no duty to indemnify.
CONCLUSION
For the reasons set forth above, the Court shall GRANT Hartford’s Motion for Summary
Judgment (D.E. No. 15) and DENY Vitamin Health’s Motion for Partial Summary Judgment
16
(D.E. No. 17).
IT IS SO ORDERED.
S/Sean F. Cox
Sean F. Cox
United States District Judge
Dated: May 9, 2016
I hereby certify that a copy of the foregoing document was served upon counsel of record on
May 9, 2016, by electronic and/or ordinary mail.
S/Jennifer McCoy
Case Manager
17
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?